Vicarious Surgical закрывается: робохирургический стартап после $300 млн и SPAC

Vicarious Surgical, an American surgical robotics developer, has officially wound down operations — The Robot Report reported this in July 2026. Over its entire existence, the company raised about $300M, and most of that amount came not from classic venture rounds, but from a SPAC merger in 2021.

How much money did the startup raise

Vicarious Surgical raised around $300M over its years of operation, and the lion's share of that capital came from going public via a SPAC in 2021, according to The Robot Report. The company was founded in 2014 in Waltham, Massachusetts; its early investors reportedly included well-known figures, including Bill Gates.

• About $300M — total capital raised
• 2021 — went public via a SPAC merger (NYSE: RBOT)
• 2014 — company founded in Waltham, Massachusetts
• Single-port robot for minimally invasive surgery through a single incision
• July 2026 — shutdown announcement

Why the SPAC didn't save the company

The 2021 SPAC merger gave Vicarious Surgical hundreds of millions of dollars, but it didn't solve the main problem — the startup never got a commercially available product. 2021 was the peak of the SPAC boom: dozens of unprofitable tech companies went public through "blank-check" holding companies, bypassing the strict classic IPO process. For hardware, this turned out to be especially risky.

Developing a surgical robot means years of engineering work and a long path to FDA clearance, not a fast software release cycle. Vicarious Surgical was designing a single-port system with miniature "human-like" arms inserted through a single incision. Such a product requires clinical trials and regulatory certification, and all that time the company was spending its raised capital without any revenue. By 2026, the money ran out before the robot reached operating rooms.

Vicarious

Surgical raised about $300M, most of it during the 2021 SPAC merger.

> — according to The Robot Report

What this means

The shutdown of Vicarious Surgical is another symptom of the sobering-up after the 2021 SPAC boom: capital raised on hype doesn't substitute for a finished product and regulatory approval. For robotics hardware with long development cycles, this is an especially harsh lesson — the money runs out faster than the technology matures for the market.

FAQ

How much money did Vicarious Surgical raise?

According to The Robot Report, the company raised about $300M over its entire existence. Most of that amount came not through venture rounds, but through a SPAC merger in 2021.

How did Vicarious Surgical go public?

The company went public in 2021 not through a classic IPO, but through a merger with a SPAC — a special "blank-check" holding company created to quickly take private companies public. Shares traded on the NYSE under the ticker RBOT.